Privia Health Group (PRVA) Stock Forecast, Price Target & Predictions
PRVA Stock Forecast
Privia Health Group stock forecast is as follows: an average price target of $33.82 (represents a 79.99% upside from PRVA’s last price of $18.79) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
PRVA Price Target
The average price target for Privia Health Group (PRVA) is $33.82 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $51.00 to $19.00. This represents a potential 79.99% upside from PRVA's last price of $18.79.
PRVA Analyst Ratings
According to 11 Wall Street analysts, Privia Health Group's rating consensus is 'Buy'. The analyst rating breakdown for PRVA stock is 0 'Strong Buy' (0.00%), 9 'Buy' (81.82%), 2 'Hold' (18.18%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Privia Health Group Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 26, 2024 | Michael Ha | Robert W. Baird | $24.00 | $21.03 | 14.12% | 27.73% |
| Aug 08, 2024 | Elizabeth Anderson | Evercore ISI | $22.00 | $19.35 | 13.70% | 17.08% |
| May 20, 2024 | Andrew Mok | Barclays | $19.00 | $16.90 | 12.43% | 1.12% |
| May 15, 2024 | Jailendra Singh | Truist Financial | $24.00 | $18.05 | 32.96% | 27.73% |
| Dec 08, 2022 | - | UBS | $30.00 | $23.31 | 28.70% | 59.66% |
| Nov 17, 2022 | Canaccord Canaccord | Canaccord Genuity | $43.00 | $24.04 | 78.87% | 128.85% |
| Nov 11, 2022 | - | Leerink Partners | $39.00 | $28.53 | 36.70% | 107.56% |
| Aug 25, 2022 | - | Canaccord Genuity | $50.00 | $42.49 | 17.67% | 166.10% |
| Aug 12, 2022 | - | Truist Financial | $48.00 | $38.43 | 24.90% | 155.46% |
| Aug 12, 2022 | - | Credit Suisse | $41.00 | $38.55 | 6.36% | 118.20% |
The latest Privia Health Group stock forecast, released on Aug 26, 2024 by Michael Ha from Robert W. Baird, set a price target of $24.00, which represents a 14.12% increase from the stock price at the time of the forecast ($21.03), and a 27.73% increase from PRVA last price ($18.79).
Privia Health Group Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 4 |
| Avg Price Target | $24.00 | $23.00 | $22.25 |
| Last Closing Price | $18.79 | $18.79 | $18.79 |
| Upside/Downside | 27.73% | 22.41% | 18.41% |
In the current month, the average price target of Privia Health Group stock is $24.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 27.73% increase as opposed to Privia Health Group's last price of $18.79. This month's average price target is up 4.35% compared to last quarter, and up 7.87% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 14, 2024 | RBC Capital | Equal-Weight | Equal-Weight | Hold |
| Aug 14, 2024 | Evercore ISI | Underperform | Underperform | Hold |
| Aug 08, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| May 20, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Feb 03, 2023 | Goldman Sachs | - | Buy | Initialise |
| Dec 08, 2022 | UBS | - | Buy | Initialise |
| Nov 11, 2022 | Canaccord Genuity | Buy | Buy | Hold |
| Aug 25, 2022 | Canaccord Genuity | Buy | Buy | Hold |
| Aug 12, 2022 | Guggenheim | Buy | Buy | Hold |
| Aug 12, 2022 | Credit Suisse | Outperform | Outperform | Hold |
Privia Health Group's last stock rating was published by RBC Capital on Aug 14, 2024. The company gave PRVA a "Equal-Weight" rating, the same as its previous rate.
Privia Health Group Financial Forecast
Privia Health Group Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $440.83M | $417.28M | $413.35M | $386.28M | $364.42M | $342.90M | $335.54M | $313.80M | $275.33M | $251.52M | $225.76M | $213.61M |
| Avg Forecast | $528.11M | $506.10M | $523.89M | $508.15M | $515.57M | $509.89M | $511.62M | $496.45M | $420.65M | $414.75M | $411.50M | $393.55M | $427.11M | $410.51M | $392.09M | $378.15M | $332.64M | $318.22M | $313.33M | $295.12M | $226.09M | $215.15M | $214.98M | $197.32M |
| High Forecast | $550.58M | $527.63M | $546.18M | $529.76M | $537.50M | $531.58M | $533.38M | $517.57M | $438.55M | $420.26M | $429.01M | $410.30M | $429.60M | $427.97M | $408.77M | $394.24M | $346.79M | $331.76M | $322.97M | $304.20M | $233.05M | $221.77M | $221.59M | $203.39M |
| Low Forecast | $510.02M | $488.76M | $505.95M | $490.74M | $497.91M | $492.42M | $494.09M | $479.44M | $406.24M | $409.80M | $397.40M | $380.07M | $418.50M | $396.44M | $378.65M | $365.19M | $321.25M | $307.32M | $303.74M | $286.08M | $219.17M | $208.56M | $208.40M | $191.28M |
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.02% | 1.05% | 1.02% | 1.10% | 1.08% | 1.07% | 1.06% | 1.22% | 1.17% | 1.05% | 1.08% |
Privia Health Group's average Quarter revenue forecast for Mar 24 based on 4 analysts is $393.55M, with a low forecast of $380.07M, and a high forecast of $410.30M. PRVA's average Quarter revenue forecast represents a -10.72% decrease compared to the company's last Quarter revenue of $440.83M (Dec 23).
Privia Health Group EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $3.19M | $6.97M | $9.58M | $8.05M | $3.38M | $-3.42M | $-4.08M | $-10.43M | $-18.32M | $-10.57M | $-191.80M | $8.35M |
| Avg Forecast | $-17.03M | $-16.32M | $-16.90M | $-16.39M | $-16.63M | $-16.44M | $-16.50M | $-16.01M | $-13.57M | $-13.38M | $-13.27M | $-12.69M | $-13.77M | $-13.24M | $-12.65M | $-12.20M | $-10.73M | $-15.80M | $-10.11M | $-17.73M | $-7.29M | $-6.94M | $-260.69M | $-6.36M |
| High Forecast | $-16.45M | $-15.76M | $-16.32M | $-15.83M | $-16.06M | $-15.88M | $-15.94M | $-15.46M | $-13.10M | $-13.22M | $-12.82M | $-12.26M | $-13.50M | $-12.79M | $-12.21M | $-11.78M | $-10.36M | $-12.64M | $-9.80M | $-14.19M | $-7.07M | $-6.73M | $-208.55M | $-6.17M |
| Low Forecast | $-17.76M | $-17.02M | $-17.62M | $-17.09M | $-17.34M | $-17.14M | $-17.20M | $-16.69M | $-14.14M | $-13.55M | $-13.84M | $-13.23M | $-13.86M | $-13.80M | $-13.18M | $-12.71M | $-11.18M | $-18.96M | $-10.42M | $-21.28M | $-7.52M | $-7.15M | $-312.82M | $-6.56M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.23% | -0.53% | -0.76% | -0.66% | -0.32% | 0.22% | 0.40% | 0.59% | 2.51% | 1.52% | 0.74% | -1.31% |
4 analysts predict PRVA's average Quarter EBITDA for Mar 24 to be $-12.69M, with a high of $-12.26M and a low of $-13.23M. This is -497.64% lower than Privia Health Group's previous annual EBITDA (Dec 23) of $3.19M.
Privia Health Group Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $2.84M | $5.64M | $7.27M | $7.32M | $17.78M | $556.00K | $-11.38M | $-18.09M | $-11.89M | $-10.89M | $-173.49M | $5.40M |
| Avg Forecast | $9.25M | $10.07M | $11.44M | $6.07M | $7.94M | $8.21M | $8.15M | $5.89M | $6.21M | $5.77M | $5.66M | $5.98M | $5.22M | $6.17M | $7.01M | $7.70M | $1.51M | $-13.63M | $253.27K | $-31.52M | $-15.83M | $-16.92M | $-234.51M | $5.43M |
| High Forecast | $9.76M | $10.63M | $12.08M | $6.41M | $8.38M | $8.66M | $8.60M | $6.21M | $6.55M | $8.08M | $5.97M | $6.31M | $7.30M | $6.51M | $7.40M | $8.13M | $1.60M | $-10.90M | $263.40K | $-25.21M | $-15.20M | $-16.24M | $-187.60M | $5.65M |
| Low Forecast | $8.84M | $9.63M | $10.93M | $5.80M | $7.59M | $7.84M | $7.78M | $5.62M | $5.93M | $4.62M | $5.41M | $5.71M | $3.13M | $5.89M | $6.70M | $7.36M | $1.45M | $-16.35M | $243.19K | $-37.82M | $-16.47M | $-17.59M | $-281.41M | $5.21M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.54% | 0.91% | 1.04% | 0.95% | 11.74% | -0.04% | -44.94% | 0.57% | 0.75% | 0.64% | 0.74% | 0.99% |
Privia Health Group's average Quarter net income forecast for Mar 24 is $5.98M, with a range of $5.71M to $6.31M. PRVA's average Quarter net income forecast represents a 110.63% increase compared to the company's last Quarter net income of $2.84M (Dec 23).
Privia Health Group SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $35.85M | $34.47M | $32.76M | $31.24M | $33.33M | $37.31M | $37.93M | $40.77M | $43.12M | $38.50M | $179.84M | $17.18M |
| Avg Forecast | $64.65M | $61.95M | $64.13M | $62.20M | $63.11M | $62.42M | $62.63M | $60.77M | $51.49M | $50.77M | $50.37M | $48.18M | $52.28M | $50.25M | $48.00M | $46.29M | $40.72M | $57.55M | $38.36M | $73.39M | $27.68M | $26.34M | $26.32M | $24.15M |
| High Forecast | $67.40M | $64.59M | $66.86M | $64.85M | $65.80M | $65.07M | $65.29M | $63.36M | $53.68M | $51.45M | $52.52M | $50.23M | $52.59M | $52.39M | $50.04M | $48.26M | $42.45M | $69.07M | $39.54M | $88.07M | $28.53M | $27.15M | $27.13M | $24.90M |
| Low Forecast | $62.43M | $59.83M | $61.93M | $60.07M | $60.95M | $60.28M | $60.48M | $58.69M | $49.73M | $50.16M | $48.65M | $46.53M | $51.23M | $48.53M | $46.35M | $44.70M | $39.32M | $46.04M | $37.18M | $58.71M | $26.83M | $25.53M | $25.51M | $23.42M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.69% | 0.68% | 0.67% | 0.82% | 0.65% | 0.99% | 0.56% | 1.56% | 1.46% | 6.83% | 0.71% |
Privia Health Group's average Quarter SG&A projection for Mar 24 is $48.18M, based on 4 Wall Street analysts, with a range of $46.53M to $50.23M. The forecast indicates a 34.39% rise compared to PRVA last annual SG&A of $35.85M (Dec 23).
Privia Health Group EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.02 | $0.05 | $0.06 | $0.06 | $0.16 | $0.01 | $-0.10 | $-0.17 | $-0.11 | $-0.10 | $-1.69 | $0.05 |
| Avg Forecast | $0.07 | $0.08 | $0.09 | $0.05 | $0.06 | $0.07 | $0.07 | $0.05 | $0.05 | $0.05 | $0.05 | $0.05 | $0.04 | $0.05 | $0.06 | $0.06 | $0.01 | $0.02 | - | $-0.01 | $-0.13 | $-0.14 | $-0.85 | $0.04 |
| High Forecast | $0.08 | $0.08 | $0.10 | $0.05 | $0.07 | $0.07 | $0.07 | $0.05 | $0.05 | $0.06 | $0.05 | $0.05 | $0.06 | $0.05 | $0.06 | $0.06 | $0.01 | $0.02 | - | $-0.01 | $-0.12 | $-0.13 | $-0.82 | $0.05 |
| Low Forecast | $0.07 | $0.08 | $0.09 | $0.05 | $0.06 | $0.06 | $0.06 | $0.04 | $0.05 | $0.04 | $0.04 | $0.05 | $0.02 | $0.05 | $0.05 | $0.06 | $0.01 | $0.02 | - | $-0.01 | $-0.13 | $-0.14 | $-0.89 | $0.04 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.55% | 0.98% | 1.12% | 0.98% | 13.24% | 0.24% | -49.48% | 14.35% | 0.87% | 0.74% | 1.98% | 1.20% |
According to 4 Wall Street analysts, Privia Health Group's projected average Quarter EPS for Mar 24 is $0.05, with a low estimate of $0.05 and a high estimate of $0.05. This represents a 110.13% increase compared to PRVA previous annual EPS of $0.02 (Dec 23).
Privia Health Group Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CERT | Certara | $10.83 | $21.75 | 100.83% | Hold |
| DH | Definitive Healthcare | $4.74 | $9.50 | 100.42% | Hold |
| PRVA | Privia Health Group | $18.80 | $33.82 | 79.89% | Buy |
| SLP | Simulations Plus | $31.89 | $56.00 | 75.60% | Buy |
| EVH | Evolent Health | $30.54 | $44.00 | 44.07% | Buy |
| HQY | HealthEquity | $78.80 | $97.00 | 23.10% | Buy |
PRVA Forecast FAQ
Is Privia Health Group a good buy?
Yes, according to 11 Wall Street analysts, Privia Health Group (PRVA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 81.82% of PRVA's total ratings.
What is PRVA's price target?
Privia Health Group (PRVA) average price target is $33.82 with a range of $19 to $51, implying a 79.99% from its last price of $18.79. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Privia Health Group stock go up soon?
According to Wall Street analysts' prediction for PRVA stock, the company can go up by 79.99% (from the last price of $18.79 to the average price target of $33.82), up by 171.42% based on the highest stock price target, and up by 1.12% based on the lowest stock price target.
Can Privia Health Group stock reach $30?
PRVA's average twelve months analyst stock price target of $33.82 supports the claim that Privia Health Group can reach $30 in the near future.
What is Privia Health Group's current price target trend?
1 Wall Street analyst forecast a $24 price target for Privia Health Group (PRVA) this month, up 27.73% from its last price of $18.79. Compared to the last 3 and 12 months, the average price target increased by 22.41% and increased by 18.41%, respectively.
What are Privia Health Group's analysts' financial forecasts?
Privia Health Group's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.03B (high $2.12B, low $1.96B), average EBITDA is $-65.585M (high $-63.338M, low $-68.375M), average net income is $30.19M (high $31.86M, low $28.84M), average SG&A $248.93M (high $259.52M, low $240.4M), and average EPS is $0.241 (high $0.254, low $0.23). PRVA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.07B (high $2.15B, low $2B), average EBITDA is $-66.64M (high $-64.357M, low $-69.475M), average net income is $36.84M (high $38.88M, low $35.2M), average SG&A $252.93M (high $263.7M, low $244.27M), and average EPS is $0.294 (high $0.31, low $0.281).
Did the PRVA's actual financial results beat the analysts' financial forecasts?
Based on Privia Health Group's last annual report (Dec 2023), the company's revenue was $1.66B, beating the average analysts forecast of $1.61B by 3.10%. Apple's EBITDA was $27.18M, missing the average prediction of $-51.856M by -152.42%. The company's net income was $23.08M, missing the average estimation of $26.1M by -11.58%. Apple's SG&A was $134.32M, missing the average forecast of $196.82M by -31.76%. Lastly, the company's EPS was $0.19, missing the average prediction of $0.208 by -8.77%. In terms of the last quarterly report (Dec 2023), Privia Health Group's revenue was $440.83M, beating the average analysts' forecast of $427.11M by 3.21%. The company's EBITDA was $3.19M, missing the average prediction of $-13.775M by -123.17%. Privia Health Group's net income was $2.84M, missing the average estimation of $5.22M by -45.61%. The company's SG&A was $35.85M, missing the average forecast of $52.28M by -31.43%. Lastly, the company's EPS was $0.0227, missing the average prediction of $0.0416 by -45.48%